Free Trial

Balkrishan Kalra Sells 55,000 Shares of Genpact (NYSE:G) Stock

Genpact logo with Computer and Technology background

Key Points

  • Genpact CEO Balkrishan Kalra sold 55,000 shares of the company's stock for a total of $2,384,800, resulting in a 15.70% decrease in his ownership position.
  • The company reported $1.25 billion in revenue for the latest quarter, surpassing analyst estimates, and set FY 2025 guidance with an anticipated EPS of 3.51-3.58.
  • A quarterly dividend of $0.17 per share has been announced, with a dividend yield of 1.6%, reflecting a payout ratio of 22.59%.
  • Five stocks we like better than Genpact.

Genpact Limited (NYSE:G - Get Free Report) CEO Balkrishan Kalra sold 55,000 shares of the company's stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer owned 295,246 shares in the company, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Genpact Stock Up 1.2%

G traded up $0.48 during trading on Wednesday, hitting $41.81. 562,486 shares of the company's stock were exchanged, compared to its average volume of 1,625,604. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $44.27 and its two-hundred day moving average is $45.71. Genpact Limited has a fifty-two week low of $37.82 and a fifty-two week high of $56.76. The stock has a market cap of $7.29 billion, a P/E ratio of 13.94, a PEG ratio of 1.45 and a beta of 0.92.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The business's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be paid a $0.17 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.6%. Genpact's dividend payout ratio is presently 22.59%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cornerstone Planning Group LLC bought a new stake in Genpact in the 1st quarter valued at $27,000. Richardson Financial Services Inc. bought a new stake in Genpact in the 1st quarter valued at $35,000. SVB Wealth LLC bought a new stake in Genpact in the 1st quarter valued at $41,000. Steph & Co. acquired a new stake in Genpact in the 2nd quarter valued at $37,000. Finally, Huntington National Bank increased its stake in Genpact by 208.2% in the 2nd quarter. Huntington National Bank now owns 906 shares of the business services provider's stock valued at $40,000 after buying an additional 612 shares during the last quarter. Institutional investors own 96.03% of the company's stock.

Analyst Upgrades and Downgrades

G has been the subject of several recent analyst reports. Mizuho upped their target price on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. JPMorgan Chase & Co. reduced their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Needham & Company LLC upped their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a research note on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $52.29.

Check Out Our Latest Stock Analysis on Genpact

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Insider Buying and Selling by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines